GLAND.NS
GLAND.NS
INE068V01023
GLAND PHARMA LIMITED
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 64.029.020.000 55.836.260.000
14.7%
Cost of Revenue 22.429.300.000 20.903.810.000
7.3%
Gross Profit 41.599.720.000 34.932.450.000
19.1%
29.533.480.000 26.032.430.000
13.4%
Operating Income 12.066.240.000 8.900.020.000
35.6%
Pretax Income 14.645.800.000 10.626.580.000
37.8%
Net Income Common Stockholders 10.273.160.000 6.985.260.000
47.1%
-- --
--
-- --
--
ende